Background This systematic review provides updated insights, from the published literature
in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) …

Beyond its use as an antiepileptic drug, over time valproate has been increasingly used for
several other therapeutic applications. Among these, the antineoplastic effects of valproate …

Seizures are a frequent complication of adult-type diffuse gliomas, and are often difficult to
control with medications. Gliomas with mutations in isocitrate dehydrogenase 1 or 2 …

Management of epilepsy in brain tumor patients : Current Opinion in Oncology Management
of epilepsy in brain tumor patients : Current Opinion in Oncology Log in or Register Subscribe …

Objective This study aimed to directly compare the effectiveness of first‐line monotherapy
levetiracetam (LEV) versus enzyme‐inducing antiseizure medications (EIASMs) in glioma …

Background This study aimed at investigating antiepileptic drug (AED) prescription
preferences in patients with brain tumor-related epilepsy (BTRE) among the European …

Glioblastoma (GBM) is characterized by fast-growing cells, genetic and phenotypic
heterogeneity, and radio-chemo-therapy resistance, contributing to its dismal prognosis …

Seizures are among the most common clinical signs in people with glioblastoma. Advances
over the past 5 years, including new clinical trial data, have increased the understanding of …

(1) Background: Epilepsy is a frequent comorbidity in patients with brain tumors, in whom
seizures are often drug-resistant. Current evidence suggests that excess of glutamatergic …

Purpose Lacosamide (LCM) is a third-generation anti-seizure medication (ASM) approved
for focal onset epilepsy in patients aged≥ 4.378 Previous studies have reported an efficacy …